J&J’s Spravato receives FDA label expansion for depression monotherapy
Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy ...
Le Lézard4h
Ultrasound Market worth $13.87 billion in 2030 with 6.8% CAGR | MarketsandMarketstm
The global Ultrasound Market, The global ultrasound market, valued at US$8.65 billion in 2023, is forecasted to grow at a robust CAGR of 6.8%, reaching US$9.32 billion in 2024 and an impressive US$13.
Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of ...
Axsome Therapeutics participates in a conference call with William Blair
Conference call with management will be held on January 23 at 2 pm hosted by William Blair. Invest with Confidence: Follow TipRanks' Top Wall ...
H.C. Wainwright Reiterates Buy Rating on Axsome Shares
H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...